1. Home
  2. FIGR vs BLCO Comparison

FIGR vs BLCO Comparison

Compare FIGR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FIGR

Figure Technology Solutions Inc.

HOLD

Current Price

$40.50

Market Cap

7.0B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.17

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIGR
BLCO
Founded
2018
1853
Country
United States
Canada
Employees
602
N/A
Industry
Finance: Consumer Services
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.9B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
FIGR
BLCO
Price
$40.50
$16.17
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$53.22
$18.45
AVG Volume (30 Days)
3.7M
479.1K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$69.23
$8.65
Revenue Next Year
$24.25
$5.59
P/E Ratio
$134.36
N/A
Revenue Growth
N/A
6.47
52 Week Low
$25.01
$10.99
52 Week High
$78.00
$18.92

Technical Indicators

Market Signals
Indicator
FIGR
BLCO
Relative Strength Index (RSI) 59.75 48.97
Support Level $40.30 $15.36
Resistance Level $42.98 $16.61
Average True Range (ATR) 3.01 0.48
MACD 0.58 0.04
Stochastic Oscillator 67.34 73.91

Price Performance

Historical Comparison
FIGR
BLCO

About FIGR Figure Technology Solutions Inc.

Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: